Concretely: CPC · liraglutide.
I would like to know the limits of what can be inferred from this.
What I am trying to avoid is over-reading a single result, which I have done before.
What would I need in addition before this supported a decision?
The part that matters: the certificate is only as useful as the lot number, because without traceability it is gossip about someone else's material.
A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
| Δ mass (Da) | Most likely cause | Distinguishing feature |
|---|---|---|
| +1 | Deamidation (Asn or Gln) | New peak, slightly earlier retention |
| −17 | Loss of ammonia | Often with deamidation |
| −18 | Dehydration / succinimide | pH-dependent, reversible |
| +16 | Oxidation (Met, Trp) | Earlier retention, light-related |
| −128 | Missing Gln or Lys | Deletion sequence from synthesis |
| 0 | Isomer: racemisation or scrambling | Same mass, shifted retention |
It helps to be literal here: test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.
The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.
If the certificate does not trace to your vial, it is not evidence about your vial.
edited 11 Dec 2025 by sasha_ferreira — corrected a unit error in the worked example
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsConcretely, what makes a certificate useful is not its appearance but whether you could hand it to another laboratory and they would reproduce the result.
Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.
More usefully, comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.
Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.
Be careful not to over-read this — a certificate that is imperfect is not worthless, it is just a starting point for thought rather than an endpoint.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
The relevant detail is that start from what the certificate claims to measure and what the claimed measurement actually answers, because those are two different questions.
Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.
Specifically, the test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.
Industry guidance on this topic is consistent because it comes from first principles rather than convention.
Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.
My working rule is that a document without a lot number, a method section and a test date is marketing.
Mechanically, a certificate without a method section is giving you a claim rather than a measurement, and claims are not evidence.
Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.
Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.
The limitation is cost — truly rigorous testing on every lot is expensive enough that most people do not do it, which is exactly why the variation matters.
If the certificate does not trace to your vial, it is not evidence about your vial.
edited 10 Jan 2026 by t_oyelaran — fixed an arithmetic slip in the third paragraph
On the detail: reading a certificate means checking four things before anything else: traceability to your vial, the test date, the analytical method, and the identity of the testing laboratory.
The certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.
The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.